Evidence map›Paper›PMID 39988838›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2025

Predictive Value of Wells, Geneva, Bova, and PESI Scores in Elderly Pulmonary Embolism Patients.

Miray Tümer

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Impact of Onset Timing on 6-Month All-Cause Mortality in Hospital-Associated Pulmonary Embolism: A Retrospective Cohort Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Miray TümerEmergency Department, Ministry of Health Ankara City Hospital, Ankara, Turkey.ORCID 0000-0002-3917-0213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND This retrospective study aimed to compare the Wells score, Geneva score, Bova score, and Pulmonary Embolism Severity Index (PESI) in the prediction of 30-day mortality and survival outcomes in 200 geriatric patients with a diagnosis of pulmonary embolism (PE). MATERIAL AND METHODS We reviewed the records of 200 patients (≥65 years old) admitted to the Emergency Department between May 2019 and December 2019 with a diagnosis of PE confirmed by computed tomography pulmonary angiography. Demographic variables, comorbidities, mental status, and laboratory data were collected. The Wells score, Geneva score, Bova score, and PESI were calculated for each patient. Primary outcome was 30-day mortality. RESULTS Among these 200 elderly patients, the presence of malignancy (P<0.05) and altered mental status (P<0.05) were significantly associated with 30-day mortality. When analyzed categorically, only the PESI score showed a significant relationship with mortality (P<0.05). However, when considering numeric values, the Bova (P<0.001), Geneva (P=0.028), and PESI (P<0.001) scores all significantly predicted 30-day mortality. CONCLUSIONS The findings suggest that PESI alone is a strong predictor of short-term mortality when evaluated categorically, while Bova, Geneva, and PESI scores provide significant prognostic information in numeric form. This underscores the importance of detailed scoring in identifying high-risk older patients with PE, which can guide treatment decisions and potentially improve clinical outcomes.

Indexed as

Pulmonary EmbolismAgedAged, 80 and overComputed Tomography AngiographyFemaleHumansMalePredictive Value of TestsPrognosisRetrospective StudiesRisk FactorsSeverity of Illness Index

Identifiers

PMID39988838
PMCPMC11869490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.